ABBY THIBODEAUX: Open Payments
NPI 1912652710 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,194 in 60 payments from 17 companies in 2025. Trend: 2023 $1,209 · 2024 $652 · 2025 $1,194
Food & beverage: $1,194
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 24 | $368 |
| Boston Scientific Corporation | 1 | $142 |
| Merck Sharp & Dohme LLC | 6 | $125 |
| Novartis Pharmaceuticals Corporation | 6 | $122 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $63 |
| SCPHARMACEUTICALS INC. | 3 | $54 |
| Amgen Inc. | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| Baxter Healthcare | 1 | $36 |
| GE HEALTHCARE | 1 | $32 |
Products named: CAMZYOS, General - Structural Heart, LEQVIO, VERQUVO, LifeVest, FUROSCIX, REPATHA, Kerendia.
Industry payments across MS — which companies pay providers there.
